ELS Executive Dr. Sauren Das Featured in India's Premier Business News Source

Executive Director of Excel Life Sciences, Dr. Saurendra Das was quoted today in The Economic Times, India's premier source for finance and business news. The story is focused on an important recommendation by India's Drug Technical Advisory Board. You can read more by clicking the included link:



http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/Drug-Technical-Advisory-Board-reccomends-no-compensation-if-a-drug-fails-to-deliver-desired-results-during-clinical-trials/articleshow/20920364.cms

New Journal Article Authored by Excel Life Sciences Exec

A new article focused on solutions for overcoming challenges in the conduct of global clinical trials, has been published in the Journal of Clinical Research Best Practices. Authored by Dan McDonald, SVP of Business Strategy for Excel Life Excel Life Sciences, the article, titled "Avoiding Common Pitfalls in Multinational Clinical Trials," highlights four common challenges and provides readers with straightforward and trial-tested advice. Click the link below to read the article and others in July's journal. 

Overcoming Pitfalls in Multinational Clinical Trials

Excel Life Sciences Announces Complimentary Webinar on the Regulatory Landscape in India for Clinical Trials

The environment for the conduct of clinical research in India is rapidly evolving and dynamic. Recent changes to regulatory policy are designed to create a more predictable, transparent and efficient process for the review of new India IND and NDA applications. The government is also looking to address research subject protection in a more holistic way. 

These changes and other news out of India have left clinical trial Sponsors confused and anxious about India as a destination for their future studies. Therefore, Excel Life Sciences has designed a new complimentary webinar series to provide you with current, relevant and useful information on clinical research in India today. 

Below is a description of the 1st webinar in the series, with links to the online registration form. There is no cost and no catch, but space is limited. Simply register and log into the webinar on the dates and times shown and we'll do the rest.

An Update on the Regulatory Environment for Clinical Research in India

Excel Life Sciences invites you and your colleagues to attend a complimentary 45 minute web-based seminar on the regulatory policy for new clinical trials in India.  Lead by ELS executives with a combined 50+ years of clinical research and regulatory affairs experience in India, this short, hard-hitting session will provide you with a solid understanding of how to successfully navigate today's regulatory environment in India. 

Specifically, the following topics will be addressed: 

- Brief history of clinical research in India

- History of India's clinical research regulations

- Overview of recent regulatory changes

- Goals behind changes and ELS insights

- New structure of India regulatory agency

- New clinical trial submission/review process

- Current and anticipated review timelines

- Tips for correct submissions

- Review of potential risks, mistakes to avoid

- Questions and Answers

Please click on the link below to complete your complimentary registration. 

Register for the Excel Life Sciences Webinar

or paste this link into your web browser:

http://www.anymeeting.com/PIID=E955DE85894A3A

Bonus Offer!

1. The first 20 qualified registrants will receive a free study feasibility analysis in India, conducted by Excel Life Sciences.
2. All attendees will receive a copy of the presentation materials, as well as two white papers related to clinical research in India. 

Our system will send you an automatic confirmation of your registration and reminders leading up to the event:

Two Excel Life Sciences Clinical Investigators Win Prestigious Padma Shri Award

Excel Life Sciences is proud to announce that two of its current clinical investigators are recipients of the prestigious Padma Shri Award in India. The award, which is given by the Government of India, is the 4th highest civilian award available and recognizes outstanding individuals in the fields of Medicine, Arts, Education, Industry, Literature, Science, Sports, Social Service and Public Affairs. 

Both investigators are participating in a global phase III ophthalmology study being managed by Excel Life Sciences in India. Specifically, Dr. Sundaram Natarajan of the Adityajyot Eye Hospital in Mumbai and Dr. Taraprasad Das of the L V Prasad Eye Institute (LVPEI) in Bhubaneswar were recognized in the category of Medicine.

Excel Life Sciences congratulates both physicians on their contributions to the field of Medicine and Clinical Research in India and beyond.

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators Work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India. The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own clinical research coordinators to each site, prides itself on a strong track record and focus on running ethical trials and delivering data quality and data integrity to its clients.

Please click here to read the full article

New Global Patient Recruitment Book Features ELS Executive

CenterWatch, a Boston-based Information Services company has just released a new resource for clinical research professionals responsible for conducting global clinical trials. The new guidebook, titled "Global Issues in Patient Recruitment and Retention" is authored by Diana L. Anderson-Foster, Ph.D., Founder and President of DAC Patient Recruitment Services, an Imperial Company. With over 260 pages of patient recruitment and retention tips, success stories and instruction from 14 industry experts, this resource is a must have for anyone involved in the planning and conduct of clinical trials.

 

Included in the guidebook is a special chapter focused on patient recruitment and retention in India, authored by Excel Life Sciences Sr. Vice President of Business Strategy, Mr. Dan McDonald. Mr. McDonald shares his experience and the collective experience of his ELS colleagues in the strategic planning and execution of customized patient recruitment programs in India.  

For assistance with developing a customized patient recruitment and retention program for your upcoming study please contact us using the information below, or click this link to visit our website.

To learn more about the new guidebook and to purchase a copy, please click the link below to visit the CenterWatch.com website.

 

 

 

ELS Review of USFDA Site Inspections in India Reveals Strong Focus on Quality

A review of site inspection data by Executive Director of Excel Life Sciences, Dr. Saurendra Das, has revealed that Indian sites are passing muster with one of the world’s most stringent regulatory agencies. Over a 7 year period and more than 30 site inspections, investigative sites in India have not received a single, OAI – Official Action Initiated, which is the most significant and negative of findings the agency can levy following an inspection. ELS has been directly involved with 4 of the inspections. For additional highlights, see the included slide/image. To find out how Excel Life Sciences can help your sites perform better In India, please visit our website.